For patients with CRVO, adding L-CRA as a causal-based treatment to conventional therapy reduced CVP and injection loads and offered improved BCVA.Trial registration number ACTRN12612000004864.
Nirav JoshiDeepak K. PandeyBhavita G. MistryDheeraj K. Singh
Himanshu Sekhar JenaKaren LeusPascal Van Der Voort
Shaikh Mohd. WaseemSourabh Vitthal GaikwadVishal Ashok PanditNilkanth N. Kapse
Muhammad Asghar, Shah Zeb Khan, Farooq Ahmad, Muhammad Salman Athar